Probiotics in the critically ill: A systematic review of the randomized trial evidence

Critical Care Medicine

Volumn 40, Issue 12, 2012, Pages 3290-3302

  Petrof, Elaine O ^a   Dhaliwal, Rupinder ^b   Manzanares, William ^c   Johnstone, Jennie ^d,f   Cook, Deborah ^d,e   Heyland, Daren K ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b KINGSTON GENERAL HOSPITAL   (Canada)

^c DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

^d Departments of Medicine   (Canada)

^e Departments of Clinical Epidemiology   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

critically ill; probiotics; systematic review

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

ARTICLE; CINAHL; COCHRANE LIBRARY; CRITICALLY ILL PATIENT; DATA BASE; DOSE RESPONSE; DRUG EFFECT; EMBASE; HUMAN; INFECTION; INTENSIVE CARE UNIT; LACTOBACILLUS PLANTARUM; LACTOBACILLUS RHAMNOSUS; LENGTH OF STAY; MEDLINE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; VENTILATOR ASSOCIATED PNEUMONIA; WOUND HEALING;

CRITICAL CARE; CRITICAL ILLNESS; EVIDENCE-BASED MEDICINE; HUMANS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84870238898     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e318260cc33     Document Type: Article

References (109)

1. Bäckhed F, Ley RE, Sonnenburg JL, et al: Host-bacterial mutualism in the human intestine. Science 2005; 307:1915-1920
2. Alverdy J, Holbrook C, Rocha F, et al: Gut-derived sepsis occurs when the right pathogen with the right virulence genes meets the right host: Evidence for in vivo virulence expression in Pseudomonas aeruginosa. Ann Surg 2000; 232:480-489
3. Alverdy JC, Chang EB: The re-emerging role of the intestinal microflora in critical illness and inflammation: Why the gut hypothesis of sepsis syndrome will not go away. J Leukoc Biol 2008; 83:461-466
4. Iapichino G, Callegari ML, Marzorati S, et al: Impact of antibiotics on the gut microbiota of critically ill patients. J Med Microbiol 2008; 57(Pt 8):1007-1014
5. Shimizu K, Ogura H, Goto M, et al: Altered gut flora and environment in patients with severe SIRS. J Trauma 2006; 60:126-133
6. Reid G, Jass J, Sebulsky MT, et al: Potential uses of probiotics in clinical practice. Clin Microbiol Rev 2003; 16:658-672
7. Reid G, Sanders ME, Gaskins HR, et al: New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003; 37:105-118
8. Gibson GR, Probert HM, Loo JV, et al: Dietary modulation of the human colonic microbiota: Updating the concept of prebiotics. Nutr Res Rev 2004; 17:259-275
9. Gibson GR, Roberfroid MB: Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr 1995; 125:1401-1412
10. Madsen K: Probiotics and the immune response. J Clin Gastroenterol 2006; 40: 232-234
11. Jijon H, Backer J, Diaz H, et al: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004; 126:1358-1373
12. Corr SC, Li Y, Riedel CU, et al: Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA 2007; 104:7617-7621
13. Spinler JK, Taweechotipatr M, Rognerud CL, et al: Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 2008; 14:166-171
14. Alberda C, Gramlich L, Meddings J, et al: Effects of probiotic therapy in critically ill patients: A randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2007; 85:816-823
15. Besselink MG, van Santvoort HC, Buskens E, et al; Dutch Acute Pancreatitis Study Group: Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial. Lancet 2008; 371:651-659
16. Barraud D, Blard C, Hein F, et al: Probiotics in the critically ill patient: A double blind, randomized, placebo-controlled trial. Intensive Care Med 2010; 36:1540-1547
17. Wood GC, Boucher BA, Croce MA, et al: Lactobacillus species as a cause of ventilator-associated pneumonia in a critically ill trauma patient. Pharmacotherapy 2002; 22:1180-1182
18. Heyland DK, Dhaliwal R, Drover JW, et al; Canadian Critical Care Clinical Practice Guidelines Committee: Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003; 27:355-373
19. Whelan K, Myers CE: Safety of probiotics in patients receiving nutritional support: A systematic review of case reports, randomized controlled trials, and nonrandomized trials. Am J Clin Nutr 2010; 91:687-703
20. Rayes N, Seehofer D, Neuhaus P: Prebiotics, probiotics, synbiotics in surgery-Are they only trendy, truly effective or even dangerous? Langenbecks Arch Surg 2009; 394:547-555
21. Dendukuri N, Costa V, McGregor M, et al: Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: A systematic review. CMAJ 2005; 173:167-170
22. Siempos II, Ntaidou TK, Falagas ME. Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med 2010; 38:954-962
23. Watkinson PJ, Barber VS, Dark P, et al: The use of pre-pro-and synbiotics in adult intensive care unit patients: Systematic review. Clin Nutr 2007; 26:182-192
24. Sun S, Yang K, He X, et al: Probiotics in patients with severe acute pancreatitis: A meta-analysis. Langenbecks Arch Surg 2009; 394:171-177
25. Zhang MM, Cheng JQ, Lu YR, et al: Use of pre-, pro-and synbiotics in patients with acute pancreatitis: A meta-analysis. World J Gastroenterol 2010; 16:3970-3978
26. Frohmader TJ, Chaboyer WP, Robertson IK, et al: Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: A pilot trial. Am J Crit Care 2010; 19:e1-e11
27. Morrow LE, Kollef MH, Casale TB: Probiotic prophylaxis of ventilator-associated pneumonia: A blinded, randomized, controlled trial. Am J Respir Crit Care Med 2010; 182:1058-1064
28. Sharma B, Srivastava S, Singh N, et al: Role of probiotics on gut permeability and endotoxemia in patients with acute pancreatitis: A double-blind randomized controlled trial. J Clin Gastroenterol 2011; 45:442-448
29. Ferrie S, Daley M: Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: Randomized controlled trial. JPEN J Parenter Enteral Nutr 2011; 35:43-49
30. Tan M, Zhu JC, Du J, et al: Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: A prospective randomized pilot study. Crit Care 2011; 15:R290
31. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188
32. Rücker G, Schwarzer G, Carpenter J: Arcsine test for publication bias in meta-analyses with binary outcomes. Stat Med 2008; 27:746-763
33. Review Manager (RevMan) [Computer program]. Version 5.1. Copenhagen, The Nordic Cochrane Centre, The Cochrane Collaboration, 2011
34. Guido Schwarzer: Meta: Meta-Analysis with R. R package version 1.6-1. 2010. Available at: http://CRAN.R-project.org/package=meta. Accessed March 10, 2012
35. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing. ISBN 3-900051-07-0. 2011. Available at: http://www.R-project.org/. Accessed March 10, 2012
36. Johnston BC, Goldenberg JZ, Vandvik PO, et al: Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2011; CD004827
37. Petrof EO, Claud EC, Sun J, et al: Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 2009; 15:1537-1547
38. Karczewski J, Troost FJ, Konings I, et al: Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 2010; 298:G851-G859
39. Tao Y, Drabik KA, Waypa TS, et al: Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 2006; 290:C1018-C1030
40. Yan F, Cao H, Cover TL, et al: Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 2007; 132:562-575
41. Shimizu K, Ogura H, Goto M, et al: Synbiotics decrease the incidence of septic complications in patients with severe SIRS: A preliminary report. Dig Dis Sci 2009; 54:1071-1078
42. Heyland DK, Novak F, Drover JW, et al: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944-953
43. Tempé JD, Steidel AL, Blehaut H, et al: [Prevention of diarrhea administering Saccharomyces boulardii during continuous enteral feeding]. Sem Hop 1983; 59:1409-1412
44. Schlotterer M, Bernasconi P, Lebreton F, et al: [Intérêt de Saccharomyces boulardii dans la tolérance digestive de la nutrition entérale à débit continu chez le brulé]. Nutr Clin Métabol 1987;1:31-34
45. Heimburger DC, Sockwell DG, Geels WJ: Diarrhea with enteral feeding: Prospective reappraisal of putative causes. Nutrition 1994; 10:392-396
46. Bleichner G, Bléhaut H, Mentec H, et al: Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial. Intensive Care Med 1997; 23:517-523
47. Kecskes G, Tibor B, Olah A: [Early enteral nutrition with specific lactobacillus and fibre reduces sepsis in patients with severe acute pancreatitis]. Magy Seb 2003; 56:3-8
48. Jain PK, McNaught CE, Anderson AD, et al: Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: A randomised controlled trial. Clin Nutr 2004; 23:467-475
49. Lu X, Han CM, Yu JX, et al: [Preliminary comparative study on the effects of early enteral supplementation of synbiotics on severely burned patients]. Zhonghua Shao Shang Za Zhi 2004; 20:198-201
50. Klarin B, Johansson ML, Molin G, et al: Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: A randomised open trial. Crit Care 2005; 9:R285-R293
51. McNaught CE, Woodcock NP, Anderson AD, et al: A prospective randomised trial of probiotics in critically ill patients. Clin Nutr 2005; 24:211-219
52. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, et al: Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically ill trauma patients: Early Results of a randomized controlled trial. World J Surg 2006; 30:1848-1855
53. Li YM: [Adjuvant therapy for probiotics in patients with severe acute pancreatitis: An analysis of 14 cases]. World Chinese J Digest 2007; 15:302-304
54. Oláh A, Belágyi T, Pótó L, et al: Synbiotic control of inflammation and infection in severe acute pancreatitis: A prospective, randomized, double blind study. Hepatogastroenterology 2007; 54:590-594
55. Forestier C, Guelon D, Cluytens V, et al: Oral probiotic and prevention of Pseudomonas aeruginosa infections: A randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care 2008; 12:R69
56. Klarin B, Wullt M, Palmquist I, et al: Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiol Scand 2008; 52:1096-1102
57. Knight DJ, Gardiner D, Banks A, et al: Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: A randomised, double-blind, placebo-controlled trial. Intensive Care Med 2009; 35:854-861
58. Niedzielin K, Kordecki H, Birkenfeld B: A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001; 13:1143-1147
59. McNaught CE, Woodcock NP, MacFie J, et al: A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002; 51:827-831
60. Oláh A, Belágyi T, Issekutz A, et al: Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002; 89:1103-1107
61. Prantera C, Scribano ML, Falasco G, et al: Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: A randomised controlled trial with Lactobacillus GG. Gut 2002; 51:405-409
62. Rayes N, Hansen S, Seehofer D, et al: Early enteral supply of fiber and Lactobacilli versus conventional nutrition: A controlled trial in patients with major abdominal surgery. Nutrition 2002; 18:609-615
63. Rayes N, Seehofer D, Hansen S, et al: Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002; 74:123-127
64. Anderson AD, McNaught CE, Jain PK, et al: Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004; 53:241-245
65. Woodcock NP, McNaught CE, Morgan DR, et al: An investigation into the effect of a probiotic on gut immune function in surgical patients. Clin Nutr 2004; 23:1069-1073
66. Kanazawa H, Nagino M, Kamiya S, et al: Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005; 390:104-113
67. Rayes N, Seehofer D, Theruvath T, et al: Supply of pre-and probiotics reduces bacterial infection rates after liver transplantation-A randomized, double-blind trial. Am J Transplant 2005; 5:125-130
68. Marteau P, Lémann M, Seksik P, et al: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: A randomised, double blind, placebo controlled GETAID trial. Gut 2006; 55:842-847
69. Sugawara G, Nagino M, Nishio H, et al: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized controlled trial. Ann Surg 2006; 244:706-714
70. Beausoleil M, Fortier N, Guénette S, et al: Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21:732-736
71. Hickson M, D'Souza AL, Muthu N, et al: Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: Randomised double blind placebo controlled trial. BMJ 2007; 335:80
72. Nomura T, Tsuchiya Y, Nashimoto A, et al: Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 2007; 54:661-663
73. Reddy BS, Macfie J, Gatt M, et al: Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007; 94:546-554
74. Qin HL, Zheng JJ, Tong DN, et al: Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur J Clin Nutr 2008; 62:923-930
75. Rayes N, Seehofer D, Theruvath T, et al: Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: A randomized, double-blind trial. Ann Surg 2007; 246:36-41
76. Gao XW, Mubasher M, Fang CY, et al: Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105:1636-1641
77. Cimperman L, Bayless G, Best K, et al: A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45:785-789
78. Falcão de Arruda IS, de Aguilar-Nascimento JE: Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. Clin Sci (Lond) 2004; 106:287-292
79. Spindler-Vesel A, Bengmark S, Vovk I, et al: Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: A randomized study in trauma patients. JPEN J Parenter Enteral Nutr 2007; 31:119-126
80. Gatt M, MacFie J: Randomized clinical trial of gut-specific nutrients in critically ill surgical patients. Br J Surg 2010; 97:1629-1636
81. de Felippe Júnior J, da Rocha e Silva Júnior M, Maciel FM, et al: Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). Surg Gynecol Obstet 1993; 177:383-388
82. Klarin B, Molin G, Jeppsson B, et al: Use of the probiotic Lactobacillus plantarum 299 to reduce pathogenic bacteria in the oropharynx of intubated patients: A randomised controlled open pilot study. Crit Care 2008; 12:R136
83. Gomersall CD, Joynt GM, Tan P, et al: Does routine administration of probiotics improve outcome of critically ill patients? ANZCA 2006; 34:544
84. Dadak L, Stourakava M, Kuklinek P, et al: Impact of synbiotics (Synbiotic 2000 Forte) on monocyte function in long-term ICU patients. Crit Care 2006; 10(S1):S89
85. Voudouris A, Kazamias P, Spyridaki E, et al: Benefits of symbiotic 2000 forte in critically ill patients: A randomized controlled trial. Crit Care 2005; 9(S):362
86. Rayes N, Seehofer D, Müller AR, et al: [Influence of probiotics and fibre on the incidence of bacterial infections following major abdominal surgery-Results of a prospective trial]. Z Gastroenterol 2002; 40:869-876
87. Oláh A, Belágyi T, Issekutz A, et al: [Combination of early nasojejunal feeding with modern synbiotic therapy in the treatment of severe acute pancreatitis (prospective, randomized, double-blind study)]. Magy Seb 2005; 58:173-178
88. Besselink MG, van Santvoort HC, Buskens E, et al: [Probiotic prophylaxis in patients with predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial] [Article in Dutch]. Ned Tijdschr Geneeskd 2008; 152:685-696
89. [republished from: Lancet 2008; 371:651-659]
90. Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, et al: Pro-and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009; 67:815-821
91. Bayley JL, Yan Yeung S: Probiotics for disease prevention: A focus on ventilator-associated pneumonia. Ann Pharmacother 2011; 45:1425-1432
92. Bruzzese E, Raia V, Spagnuolo MI, et al: Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: A pilot study. Clin Nutr 2007; 26:322-328
93. Söderling EM, Marttinen AM, Haukioja AL: Probiotic lactobacilli interfere with Streptococcus mutans biofilm formation in vitro. Curr Microbiol 2011; 62:618-622
94. Ma X, Mao YK, Wang B, et al: Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. Am J Physiol Gastrointest Liver Physiol 2009; 296:G868-G875
95. Rousseaux C, Thuru X, Gelot A, et al: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007; 13:35-37
96. Surawicz CM, McFarland LV, Greenberg RN, et al: The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31:1012-1017
97. D'Souza AL, Rajkumar C, Cooke J, et al: Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ 2002; 324:1361
98. McFarland LV: Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am J Gastroenterol 2006; 101:812-822
99. Beausoleil M, Fortier N, Guenette S, et al. Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21:732-736
100. Cassone M, Serra P, Mondello F, et al: Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 2003; 41:5340-5343
101. Muñoz P, Bouza E, Cuenca-Estrella M, et al: Saccharomyces cerevisiae fungemia: An emerging infectious disease. Clin Infect Dis 2005; 40:1625-1634
102. Borriello SP, Hammes WP, Holzapfel W, et al: Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36:775-780
103. Cassone M, Serra P, Mondello F, et al. Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism. J Clin Microbiol 2003; 41:5340-5343
104. Guandalini S: Probiotics for prevention and treatment of diarrhea. J Clin Gastroenterol 2011; 45(Suppl):S149-S153
105. Floch MH, Walker WA, Madsen K, et al: Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011; 45(Suppl):S168-S171
106. Kim HG, Kim NR, Gim MG, et al: Lipoteichoic acid isolated from Lactobacillus plantarum inhibits lipopolysaccharide-induced TNF-alpha production in THP-1 cells and endotoxin shock in mice. J Immunol 2008; 180:2553-2561
107. Wiedemann I, Böttiger T, Bonelli RR et al: Lipid II-based antimicrobial activity of the lantibiotic plantaricin C. Appl Environ Microbiol 2006; 72:2809-2814
108. Atrih A, Rekhif N, Moir AJ, et al: Mode of action, purification and amino acid sequence of plantaricin C19, an anti-Listeria bacteriocin produced by Lactobacillus plantarum C19. Int J Food Microbiol 2001; 68:93-104
109. Mack DR, Michail S, Wei S, et al: Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 1999; 276(4 Pt 1):G941-G950